Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 5, 2021
Keurig Dr Pepper Inc.
(Exact name of registrant as specified in its charter)
Delaware 001-33829 98-0517725
(State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.)
53 South Avenue, Burlington, Massachusetts 01803
(Address of principal executive offices, including zip code)
(Registrant’s telephone number including area code)
Not Applicable
(Former name or former address if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
     Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
     Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
     Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
     Pre-commencement communications pursuant to Rule 13e-14(c) under the Exchange Act (17 CFR 240.13e-14(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading SymbolName of each exchange on which registered
Common stockKDP
Nasdaq Stock Market LLC

Item 5.02. Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.

On March 5, 2021, the Board of Directors (the “Board”) of Keurig Dr Pepper Inc. (the “Company”) appointed Debra Sandler as an independent member of the Board, effective immediately. Ms. Sandler will serve for an initial term to expire concurrently with the terms of the other members of the Board at the Company’s 2021 annual meeting of stockholders, or until her earlier death, resignation or removal. Additionally, Ms. Sandler was appointed to the Board’s Remuneration and Nomination Committee.

There are no arrangements or understandings between Ms. Sandler and any other persons pursuant to which Ms. Sandler was appointed as a director and Ms. Sandler is not a party to any transaction with the Company reportable under Item 404(a) of Regulation S-K under the Securities Act of 1933. Ms. Sandler will participate in the compensation arrangements for non-employee directors as described in the Company’s 2020 proxy statement filed with the SEC on April 29, 2020.

A copy of the Company’s press release announcing the director appointment is attached as Exhibit 99.1 to this Form 8-K.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.
Exhibit No. Description
 Press Release - "Keurig Dr Pepper Announces Appointment of New Director to its Board"
104Cover Page Interactive Data File, formatted in Inline XBRL and included as Exhibit 101

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
Dated: March 9, 2021  
 By:  /s/ James L. Baldwin
  Name:  James L. Baldwin  
  Title:  Chief Legal Officer, General Counsel and Secretary